Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent biologic agent primarily employed for the treatment of rheumatoid arthritis. This powerful substance operates by inhibiting the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Furthermore, Actemra exhibits efficacy in the trea